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Abstract
In 2008, the National Institutes of Health (NIH) mandated that the full text of NIH-
supported articles be made freely available on PubMed Central (PMC) – the largest and
most commonly used repository of biomedical literature. This paper examines how this
“PMC mandate” impacted publishing patterns in biomedicine and researcher access to the
biomedical literature. Using ∼ 1 million NIH articles and several matched comparison sam-
ples, I find that NIH articles are more likely to be published in traditional subscription-based
journals (as opposed to “open access” journals) after the mandate. This indicates that the
mandate did not induce widespread discrimination, by subscription-based journals, against
NIH articles. I also find that the mandate did not increase the number of forward citations
to NIH articles published in subscription-based journals. This is consistent with researchers
having widespread access to the biomedical literature prior to the mandate, leaving little
room for the mandate to increase access.
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1 Introduction
Economists have long argued that scientific advancement is crucial for economic growth.
Since science is a cumulative process (Aghion et al., 2008; Aghion and Howitt, 1992; Mokyr,
2002; Murray et al., 2009; Romer, 1990; Scotchmer, 1991), its advancement depends on re-
searchers having broad access to the scientific literature. This insight has facilitated the
increasingly common practice, by departments, universities, and funding agencies, of man-
dating that affiliated scientific articles be made open access – “digital, online, free of charge,
and free of most copyright and licensing restrictions” (Suber, 2012, p. 4).1 In keeping with
this trend, the National Institutes of Health (NIH) implemented an open access mandate
in 2008, which stipulates that the full text of any NIH-funded article must be made freely
available, within 12 months of publication, on PubMed Central (PMC) – the largest and
most commonly used full-text repository of biomedical research. Since medical research
is estimated to have large economic benefits (Murphy and Topel, 2003) and the NIH is the
largest funder of biomedicine in the world (Chakma et al., 2014), the PubMed Central (PMC)
mandate is arguably the most consequential open access mandate ever enacted. This paper
examines how the NIH’s PMC mandate impacted publishing patterns in biomedicine as well
as how it impacted researcher access to the biomedical literature.2
I first examine how the PMC mandate impacts the likelihood that NIH articles are pub-
lished in open access journals relative to traditional subscription-based (toll access) journals.
To the extent that authors value “open science”, the PMC mandate reduces one of the main
costs of publishing an NIH article in a toll access journal – restricted access for potential
readers and citers – by ensuring that these articles are freely available on PubMed Central.
Thus, the mandate may induce authors of NIH articles to submit to toll access journals at
higher rates than authors of non-NIH articles. From a journal’s point-of-view, the PMC
mandate reduces proprietary control over NIH articles – again, by making them freely avail-
able on PubMed Central. Since proprietary control is necessary to earn subscription revenue,
the PMC mandate may have made toll access journals less inclined to publish NIH articles.3
1See the Registry of Open Access Repositories Mandatory Archiving Policies (ROARMAP) for a list of
open access mandates.
2Contemporaneous work by Bryan and Ozcan (2016) is the only other article (to my knoweldge) that
examines how the PMC mandate impacts access to the biomedical literature. They are primarily interested
in how the mandate impacted citations from patents to the biomedical literature. They find that patent-
to-article citations increase by between 25 to 51 percent. They find that article-to-article citations do not
significantly increase, which is consistent with my findings. More broadly, the current paper fits into an
“open science” literature that examines the extent to which restrictions on access to scientific literature and
materials can impede scientific progress (Furman and Stern, 2011; Murray et al., 2009; Sampat and Williams,
2015; Williams, 2013)
3It is notable that the Association of American Publishers, which represents all major publishers in
biomedicine, strongly opposed the PMC mandate, specifically warning that it would undermine its members’
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However, if journal editors (rather than owners) make publication decisions, this disinclina-
tion may be attenuated. Moreover, the NIH’s lack of enforcement until 2013 (Van Noorden,
2014) may have allowed journals to publish NIH articles without fear of losing control over
journal content. Thus, the net effects of the PMC mandate will depend on the relative
strengths of these “author-side” and “journal-side” effects.
To assess these effects, I first identify all (∼ 1 million) NIH-funded articles published
between 2003 and 2013 in the MEDLINE database – the largest repository of biomedical
literature in the world. Second, in order to pin down counterfactual outcomes, I construct
several sets of comparison articles that are not NIH-funded. Third, I use the Directory
of Open Access Journals (DOAJ) to determine whether an article is published in an open
access or toll access journal. Finally, I use difference-in-differences (DID) and propensity
score methods to examine the impact of the PMC mandate on the probability that an
article is published in a traditional toll access journal.
Most results indicate that the PMC mandate increased the probability that an NIH ar-
ticle is published in a toll access journal by 0-3 percentage points, with the more credible
estimates at the upper end of this range. This is consistent with author-side effects domi-
nating journal-side effects. At the very least, there is no evidence that the PMC mandate
induced widespread discrimination against NIH articles by toll access journals, which may be
due to editors, not owners, making publication decisions.4 To further check for evidence of
discrimination, I examine whether the mandate changed the probability that an NIH article
is published in the journals Science or Nature. Given their policies against publishing articles
available elsewhere (such as PubMed Central), evidence of discrimination, if it exists, should
be most pronounced with these journals. The evidence is ambiguous, but weakly suggests
that journal-side effects may dominate for particular subsets of journals.
Next, I examine whether the PMC mandate increased researcher access to the biomedical
literature. If, prior to the mandate, some researchers had difficulty accessing NIH articles,
then, after the mandate, we should observe an increase in the rate at which NIH articles are
economic incentives by making their content available online (www.publishers.org/issues/5/9). At least one
member of the publishing industry explicitly suggested that “Another possible implication (of the PMC
mandate) is that journals may no longer be willing to review and accept articles with unsustainable terms
attached” (McMullan, 2008). Though prior to the PMC mandate, Seamans (2001) found that, in a sample
of mostly non-profit journals, 17.64 percent expressed reservations about accepting submissions of theses and
dissertations available on the web. Howard (2011) documents several university press editors’ reluctance to
publish theses and dissertations that can be found “immediately on Google or by going to the university
page and just clicking and downloading it...”. Finally, as noted by (Suber, 2012, p. 173), medicine is a field
particularly likely to follow the “Ingelfinger Rule” and refuse to accept articles that have circulated online.
4It is worth noting that the “Cost of Knowledge Protest” by academics against Elsevier’s journals began
in 2012. Since the protest began near the end of my sample period (2003-2013), it is unlikely that it
substantially impacts my main results. However, to the extent that the protest does impact my results, it
likely makes my estimates smaller than they would otherwise be.
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cited in follow-on research. In particular, there should be an increase in citations to NIH
articles published in toll access journals, which prior to the mandate (and unlike NIH articles
published in open access journals), would have been unavailable to researchers without a
subscription to the journal.
Using triple differences (DDD) and propensity score methods, I find that the PMC man-
date did not increase overall access to NIH articles. This is consistent with recent work
showing that making articles open access does not increase citations to those articles.5 I also
examine how citations by researchers in poor/developing countries and researchers affiliated
with commercial enterprises are impacted by the PMC mandate. While researchers affiliated
with universities or research hospitals in rich countries may have access to the entire biomedi-
cal literature, researchers in poor countries or at commercial enterprises (especially start-ups
on a shoestring budget) may have more limited access in the absence of the mandate (Ware
and Monkman, 2009; Houghton et al., 2011). However, even for these subgroups, I find little
evidence that the mandate substantially increased access. It is important to note, however,
that these results do not indicate whether the mandate increased access for other consumers
of the biomedical literature such as doctors or inventors.
Given the non-rivalrous nature of ideas, ideas’ importance for economic growth, and the
cumulative nature of science, it is crucial to understand the impacts of restrictions (and the
lifting of restrictions) on access to scientific research. This is especially true for biomedical
research, which is estimated to yield large returns. This paper analyzes how the abolition of a
particular set of restrictions (the PMC mandate) impacts publishing patterns in biomedicine
and access to the biomedical literature.
Moving forward, the paper is organized as follows. Section 2 describes the data. Section
3 discusses the details of the PMC mandate, my econometric strategy, and the plausibility
of the identifying assumptions underlying this strategy. Section 4 presents the results, and
Section 5 concludes.
5Though the best evidence does not suggest that open access increases citations, early studies find a
large impact. Lawrence (2001) paved the way using a sample of articles from computer science conferences.
This finding is replicated in Antelman (2004) and Davis and Fromerth (2007) for mathematics, by Antelman
(2004) for philosophy, political science, and engineering, by Schwarz and Kennicutt Jr (2004) and Metcalfe
(2005, 2006) for astrophysics, by Harnad and Brody (2004) for physics, by Walker (2004) for oceanography,
and by Eysenbach (2006) for multidisciplinary science. Craig et al. (2007) provide a useful review of this
early literature. Since these early studies all use observational cross-sections, it is difficult to draw reliable
causal conclusions from their results. A more recent literature, that explicitly attempts to account for the
endogeneity of open access, has found much more modest effects. Using panel data, Evans and Reimer (2009)
and McCabe and Snyder (2014) find that open access increases citations by approximately 8 percent. Using
an instrumental variables strategy, Gaule and Maystre (2011) do not find a statistically significant impact of
open access on citations. Finally, using evidence from randomized controlled trials, Davis et al. (2008) and
Davis (2011) fail to find a statistically significant increase in the number of citations to open access articles.
4
2 Data
The data used in this paper are obtained from three main sources: MEDLINE, Web of Science
(WOS), and the Directory of Open Access Journals (DOAJ). MEDLINE is a bibliographic
database maintained by the National Library of Medicine and is the most comprehensive
index of the biomedical literature.6 It includes a large amount of information about each
indexed article, including the year and journal in which it is published and any grants that
support it (in particular, NIH grants). WOS is maintained by Clarivate Analytics’ and
indexes the references of MEDLINE articles. It enables the tracking of citation relationships
between MEDLINE articles. DOAJ is the most comprehensive index of open access journals
across all fields, and it enables the labeling of journals in MEDLINE as open or toll access.
For more details on all data, see Appendix A.
2.1 Outcome Variables
The first set of outcomes are designed to measure how the PMC mandate impacted publishing
patterns in biomedicine. I first examine whether an article is published in an open access or
toll access journal. A journal is identified as as open access if it is indexed by the Directory
of Open Access Journals (DOAJ). Otherwise, it is classified as toll access.7 Next, I examine
whether an article is published in the journals Science or Nature, which are identified using
the unique journal identifier in MEDLINE (see Appendix A). The time frame of analysis for
these two variables is 2003-2013 – 5 years before and after the 2008 PMC mandate.
The second set of outcomes are designed to measure whether the PMC mandate increased
access to the biomedical literature. I first examine the total number of 2-year forward
citations that an article receives. Next, I examine the number of 2-year forward citations
that an article receives from particular subsets of authors. First, I restrict the count of
2-year forward citations to those received by articles with authors at commercial enterprises.
Second, I restrict the count to those received by authors at institutions located in poor or
6Technically, MEDLINE is a subset of a larger database called PubMed (distinct from PubMed Central).
However, the data in MEDLINE have undergone rigorous quality control and are readily available for use
by researchers.
7For several reasons, this classification scheme is imperfect. First, some journals in MEDLINE may be
open access, but are not indexed in DOAJ. Such journals will be falsely classified as toll access. Second,
a journal may be open access (or toll access) at one point in time, and then change status. Such journals
will be correctly classified in some years and falsely classified in others. Third, some journals are neither
fully open nor fully toll access. For instance, some journals allow authors to pay a fee to make their article
open access in an otherwise toll access journal. Other journals allow some forms of “green” open access,
which allow researchers to put non-final versions of their articles on personal webpages or repositories like
PubMed Central. Still other journals embargo articles for a time and then open them to all researchers.
Unfortunately, the DOAJ data do not allow me to address these nuances.
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developing countries.8 Since the WOS citation data end in mid-2014, I end the analysis for
2-year forward citation measures in 2011, which ensures that all articles have a full 2 years
to accrue citations.
2.2 NIH Articles and Comparison Articles
There are 2,050,044 articles in MEDLINE tagged as being funded by the National Institutes
of Health (NIH).9 956,801 of these are published between 2003 and 2013 (the time frame for
the analysis of publishing patterns) and 745,076 between 2003 and 2011 (the time frame for
the analysis of researcher access).
To pin down counterfactual outcomes, I construct several sets of comparison articles
using non-NIH articles. The first comparison sample is the set of all non-NIH articles in
MEDLINE published between 2003 and 2013 (2011). There are 7,482,563 (5,809,078) such
articles. I refer to this set of comparison articles as the “MEDLINE” comparison sample.
The second set of comparison articles is the set of all non-NIH articles published in the same
journal and year as at least one NIH article.10 There are 5,792,555 (4,455,039) such articles.
I refer to this set of comparison articles as the “Journal” sample.
The third set of comparison articles is constructed using the PubMed Related Citations
Algorithm (PRCA) which identifies, for any given article, a set of “similar” articles.11 First,
I use the PRCA to harvest similar articles for each NIH article. After restricting the set
of harvested articles to those that are published in the 2003-2013 (2011) period and are
not themselves NIH articles, there are a total of 3,171,838 (2,542,714) unique comparison
articles. I refer to this set of comparison articles as the “Full PRCA” sample.
The final set of comparison articles is a subset of the Full PRCA sample. Taking ad-
vantage of the fact that the PRCA delivers a similarity score for each harvested article, I
am able to identify the particular comparison article that most closely matches each NIH
article and implement a 1-to-1 matching (without replacement) algorithm. I refer to this set
8I identify articles affiliated with a commercial enterprise using MapAffil and articles from
poor/developing countries using a combination of MapAffil and the United Nations National Accounts.
See Appendix A for details.
9MEDLINE contains two pieces of information that are used to identify NIH articles. The first is the
list of grants contained in the MEDLINE element GrantList and the second is information contained in the
element PublicationTypeListist. The National Library of Medicine (NLM) generates the GrantList using
the grants listed by authors on an article. Thus, it is possible that some articles are NIH-supported, but
are not identified as such because authors do not list the NIH grant. The PublicationTypeList is curated by
librarians at NLM in the same way that MeSH terms are curated.
10Ideally, I would use journals published in the same journal issue. However, the journal issue element in
the MEDLINE data is often missing, making this strategy infeasible.
11The harvested articles are obtained from PubMed, a superset of the MEDLINE database. The algorithm
defines similarity using overlapping MeSH terms and text in titles and abstracts.
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of comparison articles as the “1-to-1 PRCA” sample.
In sum, I construct four comparison samples in order to estimate counterfactual outcomes:
The “MEDLINE”, “Journal”, “Full PRCA”, and “1-to-1 PRCA” samples.
2.3 Covariates
The data allow me to construct a rich set of article-level covariates. These include the
number of backward citations, the number of backward citations published in open access
journals, the number of unique n-grams (1-, 2-, and 3-) that an article uses in either the
title or abstract, the number of top n-grams an article “originates”, the number top n-grams
for which an article is an “early adopter”,12 the number of “Descriptor” Medical Subject
Heading (MeSH) terms13 that tag an article, the number of “Qualifier” MeSH terms that tag
an article, the number of authors, an indicator for whether the author is a corporate entity,
a set of indicator variables for the type of institution to which the first author belongs (e.g.
university, hospital, etc.), a set of fixed effects for the country in which the first author works,
a set of indicator variables characterizing an article’s “Publication Type” (e.g. whether the
article is a review article, a clinical trial, etc.), a set of indicator variables characterizing
the languages in which the article is published, and the number of non-NIH grants that
support the article. I also use the MeSH terms that tag each article to construct a variable
characterizing the field of each article, which allows the inclusion of field-fixed effects in
regression models (see Appendix C for details). When the outcome variable is 2-year forward
citations, I also estimate specifications that include journal fixed effects. Journal fixed effects
cannot be included when the outcome variable is the toll access indicator because there is
no within-journal variation in this outcome. See Appendix A for details on all covariates.
2.4 Summary Statistics
Appendix Tables A.1.a through A.1.d present summary statistics for each of the four com-
parison samples. In the MEDLINE sample, the covariates are fairly imbalanced across the
NIH and comparison groups. In both the pre- and post-mandate periods, NIH articles tend
to cite more articles, use more top n-grams, are tagged with more MeSH terms, have more
authors, are less likely to have a corporate authors, are more likely to be a “Journal Article”,
12An article “originates” an n-gram if the article uses the n-gram in the n-gram’s vintage year (first year
the n-gram appears in the MEDLINE corpus). An article is an “early adopter” of an n-gram if the article
uses the n-gram within 5 years of the n-gram’s vintage. A “top” n-gram is one that, compared to all other
n-grams in its vintage, is in the top 0.01% in terms of total mentions in the MEDLINE corpus.
13Medical Subject Heading (MeSH) terms are used to classify the content of each record indexed in
MEDLINE. Librarians at the National Library of Medicine (NLM) read each article and determine which
MeSH terms apply to that article.
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are less likely to be an “Irregular Article”, and are more likely to be published in English.
Though these differences persist in the other three comparison samples, the magnitudes tend
to decrease, and the covariates in the journal, full PRCA, and 1-to-1 PRCA samples become
increasingly more balanced. Indeed, in the 1-to-1 PRCA sample, many of the covariates
are quite similar across the NIH and comparison articles, suggesting that this is the most
appropriate comparison group.
3 Research Design
3.1 Details of the NIH Public Access Policy (“PMC Mandate”)
On February 3, 2005 the National Institutes of Health (NIH) issued a policy statement that
requested all NIH-supported articles to be submitted to PubMed Central. This request
became effective on May 2, 2005.14 Despite the request, a 2006 NIH report to Congress
revealed that voluntary compliance with this request was below 4 percent.15 Thus, Congress
instructed the NIH to change the request to a mandate – the “PMC mandate”. On January
11, 2008 the NIH announced that the full text of all NIH-supported articles accepted for
publication on or after April 7, 2008 were to be submitted, in final peer-reviewed form, to
PubMed Central immediately upon acceptance for publication.16 However, authors have the
option to embargo their work for up to one year. By 2012 compliance stood at 75 percent.17
3.2 Econometric Strategy
The treatment of interest is the requirement to submit an article to PubMed Central im-
mediately upon acceptance for publication. Depending on the type of outcome variable, I
14Specifically, the policy statement read: “beginning May 2, 2005, NIH-funded investigators are requested
to submit to the NIH National Library of Medicine’s (NLM) PubMed Central (PMC) an electronic version of
the author’s final manuscript upon acceptance for publication, resulting from research supported, in whole or
in part, with direct costs from NIH.” http://grants.nih.gov/grants/guide/notice-files/NOT-OD-05-022.html.
15http://legacy.earlham.edu/ peters/fos/nihfaq.htm
16The Public Access Policy was the NIH’s response to Division G, Title II, Section 218 of PL 110-161
(Consolidated Appropriations Act, 2008), which states: “The Director of the National Institutes of Health
shall require that all investigators funded by the NIH submit or have submitted for them to the National
Library of Medicine’s PubMed Central an electronic version of their final, peer-reviewed manuscripts upon
acceptance for publication, to be made publicly available no later than 12 months after the official date of
publication: Provided, That the NIH shall implement the public access policy in a manner consistent with
copyright law.” Note that, though the article must be submitted to PubMed Central immediately upon
acceptance for publication, the author retains the option of embargoing the article for up to 12 months after
publication.
17http://www.whitehouse.gov/sites/default/files/microsites/ostp/public access-final.pdf
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use difference-in-differences (DID), triple differences (DDD), and propensity score methods
to identify the effect of this treatment.
3.2.1 Difference-in-Differences
Each article in the sample is either an NIH article (Ni = 1) or a comparison article (Ni = 0)
and is either published before (Pi = 0) or after (Pi = 1) the PMC mandate. In the difference-
in-differences (DID) framework, the impact of the mandate can be identified by estimating
the following regression equation:
Y obsi = βt + γNi + δ(Pi ×Ni) + ρXi + i. (1)
Y obsi is an observed outcome variable (for instance, a toll access indicator or an indicator for
publication in Science or Nature), βt is a full set of publication year fixed effects, Pi is an
indicator that turns on in 2009, Ni indicates whether an article is NIH-supported, and Xi is
a vector of article-level covariates. δ is the parameter of interest, measuring the impact of
the mandate under this model.
3.2.2 Triple Differences
When the outcome variable is the count of 2-year forward citations, it can be analyzed in
the DID framework above. However, articles (NIH or comparison) published in open access
journals are unlikely to be impacted by the PMC mandate because any researcher can access
and cite these articles, by definition, both before and after the mandate. Thus, if we observe
an increase in citations to NIH articles, we should observe them accruing to articles published
in toll access journals.
This observation suggests that a triple differences (DDD) framework is a more appropriate
for the citation outcomes. In this setting, an article is either published in a toll access
(“subscription”) (Si = 1) or open access (Si = 0) journal, and the impact of the mandate
can be identified by estimating the following regression equation:
Y obsi = βt+γ1Ni+γ2Si+γ3(Si×Ni)+γ4(Pi×Ni)+γ5(Pi×Si)+δ(Pi×Si×Ni)+ρXi+i. (2)
Si indicates whether article i is published in a toll access journal, and the other variables
are defined as in equation (1). Again, δ is the parameter of interest, measuring the impact
of the PMC mandate under the DDD model.
Figure 1 assesses the common trends assumption that underlies the DID and DDD models
by plotting pre-mandate trends for the two main outcome variables of interest: an indicator
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for whether an article is published in a toll access journal and the count of 2-year forward
citations. Since the count of 2-year forward citations is analyzed in a DDD framework,
the trends of this variable are also broken down by whether an article is published in a
toll or open access journal. The graphs suggest that, for both outcomes and across all
four comparison samples, the common trends assumption is reasonably satisfied during the
pre-mandate period.
3.2.3 Stratified Difference-in-Differences
An additional assumption underlying the DID/DDD models is that the composition of groups
is constant over time (Blundell and Dias, 2009). Concern over whether this assumption holds
is especially salient when the data are repeated cross-sections and different units continually
enter and leave the sample (Stuart et al., 2014). To deal with the possibility of changing group
composition, I use a method that combines propensity score stratification and DID/DDD
regression.18
As a first step, I estimate the propensity scores for the DID and DDD settings, P (Ni =
1, Pi = 1|Xi) and P (Ni = 1, Pi = 1, Si = 1|Xi), as function of article-level covariates. Second,
I algorithmically partition the articles into strata that have similar propensity scores. Third,
I estimate equations (1) and (2) within each stratum. Finally, I combine the estimates within
the strata into composite estimates of the the impact of the mandate.
Since the propensity scores within a stratum are relatively similar, the within-stratum
covariate distributions of the four DID and eight DDD groups are also relatively similar. This
helps alleviate concerns about composition changes within groups over time. Any additional
differences in the covariate distributions across groups are at least partially accounted for
by continuing to include covariates Xi when equations (1) and (2) are estimated within
each stratum. I also present estimates obtained from trimmed samples in which articles
with estimated propensity scores above 0.9 and below 0.1 are dropped. These articles have
covariate values at which there is very limited overlap between treated and control articles
(Crump et al., 2009). See Appendix D for details on the propensity score estimation and
stratification.
18For alternative procedures that use the propensity score in DID framework to make the constant com-
position assumption more plausible, see Stuart et al. (2014) or Blundell et al. (2004).
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4 Results
4.1 Publishing Patterns in Biomedicine
Figure 2 displays the point estimates, along with 95% confidence intervals,19 of the PMC
mandate’s impact on the probability that an NIH article is published in a toll access journal
(δ in equation 1). For each of the four comparison samples, estimates are obtained with
and without covariates, with and without stratification, and on the trimmed and untrimmed
samples.
All estimates, across all four comparison samples, are positive. When the entire
(untrimmed) MEDLINE sample is used without stratification or covariates, the estimate
is quite imprecise. Adding covariates slightly increases precision, while trimming and strat-
ifying greatly increase precision. Overall the estimates from the MEDLINE sample range
from 0.004 to 0.016. The estimates obtained using the journal sample follow a very similar
pattern, ranging from 0.006 to 0.018. In addition to being positive, all estimates from the
two PRCA samples are statistically significant. Adding covariates and trimming does little
to improve precision, but stratifying significantly increases precision. Overall, the estimates
from the two PRCA samples range from 0.012 to 0.030. Thus, these estimates suggest that,
after the PMC mandate, the probability that an NIH article is published in a toll access
journal increases by between 0.4 to 3 percentage points.
These estimates do not support the hypothesis that the PMC mandate decreased the
probability that an NIH article is published in a toll access journal. That is, there is no
evidence that journal-side effects dominate. There is stronger evidence that the impact is
positive – that is, author-side effects dominate. Since the 1-to-1 PRCA sample is generated
in a way that increases the similarity between the NIH and comparison group, I view these
estimates as the most credible. Thus, the most credible evidence suggests that, after the
PMC mandate, the probability that an NIH article is published in a toll access journal
increased by 2-3 percentage points.
Table 1 assesses the magnitudes of these point estimates. In 2009, the year after the
PMC mandate, there were a total of 92,646 NIH-funded articles published – 5,697 (6.1%) in
open access journals and 86,949 (93.9%) in toll access journals. If the mandate increased the
probability that an NIH article is published in a toll access journal by 1 percentage point
(effect size: 0.01), then, in the absence of the mandate, only 86,023 (92.9%) NIH articles
would have been published in toll access journals. Thus, under this scenario, the mandate
shifted 86, 949 − 86, 023 = 926 NIH articles from open access to toll access journals in
19The confidence intervals are computed using standard errors clustered at the aggregated field level. See
Appendix C for details on field construction.
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2009. If we instead assume that the mandate increased the probability that an NIH article is
published in a toll access journal by 2 or 3 percentage points, then the mandate shifted 1,853
or 2,779 articles from open access to toll acccess journals. This computation can be carried
out for all years between 2009 and 2013. Overall, these estimates suggest that between 5,076
and 15,253 articles were shifted from open to toll access journals over the 2009-2013 period,
which is between 10 (= 5, 076/50, 981 ∗ 100) and 30 (= 15, 253/50, 981 ∗ 100) percent of the
NIH articles actually published in open access journals.
Figure 3 displays how these effects evolve dynamically over time. All estimates show
persistent increases in the probability that an NIH article is published in a toll access journal
after the mandate. Indeed, these increases are permanent over the period we analyze (which
helps to justify the assumption of a permanent level shift when assessing magnitudes in Table
1). However, the increase estimated from the MEDLINE sample is very slight. It is clear
that these trends are much more pronounced and precisely estimated for the two PRCA
samples.
The evidence above suggests that there is no evidence of widespread discrimination, by
toll access journals, against publishing NIH articles after the PMC mandate. However, it is
possible that certain subsets of journals discriminated against NIH articles. To probe this
possibility, I change the outcome variable in equation (1) from an indicator for publication in
a toll access journal to an indicator for publication in the journals Science or Nature. These
journals have strict policies against publishing an article that has already been circulated in
any form. Thus, if discrimination exists, it should be observable with these journals.
As will become clear, it is useful to first examine the dynamics of this outcome variable,
which are displayed in Figure 4. Across all four comparison samples, the probability of NIH
articles (relative to comparison articles) being published in Science or Nature is trending
upward in the pre-mandate period. Then, in the post-mandate period, this trend suddenly
stops. This suggests that there are group-specific trends that are not accounted for by the
standard DID model. Indeed, since the relative probability of an NIH article being published
in Science or Nature is higher in the post-mandate period, a standard DID model will yield
misleading positive estimates of the effect of the mandate.
To deal with this issue, I estimate both the standard DID model and a model that adds
a linear time trend interacted with the NIH indicator (Ni × t) to equation 1. Figure 5
displays these estimates. As expected, the two models generate conflicting results. The
positive estimates from the standard DID model suggest that author-side effects dominate
and the negative estimates from the linear trend DID model suggest that journal-side effects
dominate. Since there are clearly group-specific trends in the outcome, and the linear trend
DID model allows for such trends, I view these estimates as more credible. If correct, this
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suggests that journal-effects may dominate for journals, such as Science or Nature, that
have very strict policies against publishing articles that appear elsewhere. However, given
the sensitivity of these results to model selection, they should be interpreted cautiously.
In sum, the evidence suggests fairly strongly that the PMC mandate did not induce
widespread discrimination against NIH articles by toll access journals. Across a wide variety
of samples and models, the results suggest that the mandate actually increased the proba-
bility that an NIH article is published in a toll access journal, most likely by 0-3 percentage
points. This result is consistent with the PMC mandate increasing the accessibility of NIH
articles published in toll access journals and thus inducing researchers who value “open sci-
ence” to submit their work to such journals at higher rates. However, there is some less
robust evidence that the mandate decreased the probability of NIH articles being published
in toll access journals that have particularly strict policies against publishing articles that
appear elsewhere.
4.2 Access to the Biomedical Literature
Figure 6 displays the triple differences (DDD) point estimates, along with 95% confidence
intervals,20 of the PMC mandate’s impact on the count of 2-year forward citations received
by an NIH article published in a toll access journal (δ from equation 2). As in the previous
section, for each of the four comparison samples, estimates are obtained with and without
covariates, with and without stratification, and on the trimmed and untrimmed samples.
With a few exceptions, the point estimates are positive. For instance, when the entire
(untrimmed) MEDLINE sample is used without stratification or covariates, the estimate
suggests that the PMC mandate increased the number of 2-year forward citations by a
statistically significant 1.5. When article-level covariates are included, the estimate becomes
smaller (about 0.5), more precise, and statistically indistinguishable from 0.
This pattern is common across the comparison samples and estimators – adding article-
level covariates tends to increase precision and attenuate the magnitude of point estimates.
When covariates are not included, the point estimates range from 0.06 to 1.93, and these are
often statistically significant. However, when covariates are included, the point estimates
range from -0.16 to 0.73, and are typically clustered around 0. Indeed, when covariates are
included for the two PRCA samples, the estimates range from -0.16 to 0.19. Given that
the mean NIH article published in a toll access journal prior to the mandate received 10.42
2-year forward citations, these effects are quite small.
20The confidence intervals are computed using standard errors clustered at the journal level. The results
are very similar when they are clustered at the aggregated field level.
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Figure 7 displays the dynamics for 2-year forward citations. Across all four comparison
samples, the count of forward citations received by NIH articles published in toll access
journals is slightly higher in the post mandate period. However, especially for the 1-to-1
PRCA sample, this count may have been trending upward even prior to the mandate.
Overall, these estimates suggest that the PMC mandate did not substantially increase
the total number of 2-year forward citations to NIH articles published in toll access journals.
This is consistent with most researchers having broad access to the biomedical literature
prior to the mandate, leaving little room for the mandate to increase overall access.
Though the previous results suggest that the PMC mandate did not increase overall
access to the biomedical literature, it is possible that particular sub-groups of researchers
had limited access to NIH articles prior to the mandate, gaining access only after the man-
date. If so, we should be able to detect increases in 2-year forward citations from these
sub-groups to NIH articles published in toll access journals after the mandate. I examine
citations from authors affiliated with a commercial enterprise and authors affiliated with an
institution located in a poor/developing country. Commercial enterprises may be more sen-
sitive than research universities or hospitals to high journal subscription costs, limiting the
access of their researchers to articles published in toll access journals (Ware and Monkman,
2009; Houghton et al., 2011). This is especially plausible for start-ups, which may be on a
shoestring budget. Similarly, institutions located in poor/developing countries may lack the
resources to purchase broad access to the literature for their researchers.
Figures 8 and 9 display the DDD estimates when the outcome variable is 2-year forward
citations from researchers affiliated with a commercial enterprise and an institution located in
a poor/developing country. The patterns of the results are strikingly similar to the results for
total 2-year forward citations. In particular, in specifications without article-level covariates
the estimates are positive and often statistically significant. Adding covariates tends to
attenuate the magnitude of the estimates (but does not greatly increase precision). The
estimates for commercial enterprises range from -0.008 to 0.049 overall and from -0.008 to
0.018 when covariates are included. The estimates for poor/developing countries range from
-0.021 to 0.056 overall and -0.021 to 0.022 when covariates are included. Given means of 0.204
and 0.205, the upper end estimates are quite large, but more plausible estimates are quite
modest. Overall, the evidence that the PMC mandate increased access for these sub-groups
of researchers to NIH articles published in toll access journals is weak.
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5 Conclusion
This paper examined the impacts of the National Institutes of Health’s 2008 PubMed Cen-
tral (PMC) Mandate on publishing patterns in biomedicine and researcher access to the
biomedical literature. Three main findings emerge from the analysis.
First, I find no evidence that the PMC mandate induced widespread discrimination, by
toll access journals, against NIH articles. In contrast, the best evidence suggests that the
probability of an NIH article being published in a toll access journal increases after the
mandate. If researchers value “open science”, then, all else equal, they will prefer to publish
in journals that provide widespread access. Prior to the mandate, this preference may have
induced researchers to publish some articles in open access journals that would otherwise
have been published in toll access journals. Since the PMC mandate provided universal
access to NIH articles regardless of where they are published, researchers no longer had to
take the openness of the journal into account when deciding where to publish their work.
This, along with journal editors (not owners) making publication decisions, could account
for the increase the the relative proportion of NIH articles that are published in toll access
journals after the mandate.
Second, there is weak evidence that journals with particularly strict policies against pub-
lishing material that has appeared elsewhere may have discriminated against NIH articles.
For such journals, the incentive to maintain propriety control over journal content may be
strong enough to reject NIH articles that would have been published in the absence of the
mandate. This may be especially true for prestigious journals such as Science or Nature that
receive many high quality non-NIH submissions.
Third, I find little evidence that the PMC mandate increased researcher access to the
biomedical literature. Indeed, this holds even for subgroups of researchers that, a priori,
may have been suspected to have limited access to the literature. This finding is consistent
with most researchers having broad access to the biomedical literature prior to the mandate,
providing little scope for the mandate to increase access. This finding is consistent with
findings in Bryan and Ozcan (2016). However, it must be stressed that this result does
not provide evidence on whether the mandate impacted access for doctors, inventors, or
other consumers of the biomedical literature. Indeed Bryan and Ozcan (2016) find that the
mandate did increase patent citations to the NIH articles after the mandate. In follow-up
work, I will further explore the relationship between the PMC mandate and patent-to-article
citations.
15
References
Aghion, P., M. Dewatripont, and J. C. Stein (2008). Academic freedom, private-sector focus,
and the process of innovation. The RAND Journal of Economics 39 (3), 617–635.
Aghion, P. and P. Howitt (1992). A model of growth through creative destruction. Econo-
metrica 60 (2), 323–351.
Antelman, K. (2004). Do open-access articles have a greater research impact? College &
research libraries 65 (5), 372–382.
Blundell, R. and M. C. Dias (2009). Alternative approaches to evaluation in empirical
microeconomics. Journal of Human Resources 44 (3), 565–640.
Blundell, R., M. C. Dias, C. Meghir, and J. Reenen (2004). Evaluating the employment
impact of a mandatory job search program. Journal of the European Economic Associa-
tion 2 (4), 569–606.
Bryan, K. A. and Y. Ozcan (2016). The impact of open access mandates on invention.
Chakma, J., G. H. Sun, J. D. Steinberg, S. M. Sammut, and R. Jagsi (2014). Asia’s ascent:
global trends in biomedical R&D expenditures. New England Journal of Medicine 370 (1),
3–6.
Cochran, W. G. (1968). The effectiveness of adjustment by subclassification in removing
bias in observational studies. Biometrics , 295–313.
Craig, I. D., A. M. Plume, M. E. McVeigh, J. Pringle, and M. Amin (2007). Do open
access articles have greater citation impact? A critical review of the literature. Journal of
Informetrics 1 (3), 239–248.
Crump, R. K., V. J. Hotz, G. W. Imbens, and O. A. Mitnik (2009). Dealing with limited
overlap in estimation of average treatment effects. Biometrika 96 (1), 187–199.
Davis, P. M. (2011). Open access, readership, citations: A randomized controlled trial of
scientific journal publishing. The FASEB Journal 25 (7), 2129–2134.
Davis, P. M. and M. J. Fromerth (2007). Does the arXiv lead to higher citations and reduced
publisher downloads for mathematics articles? Scientometrics 71 (2), 203–215.
Davis, P. M., B. V. Lewenstein, D. H. Simon, J. G. Booth, M. J. Connolly, et al. (2008).
Open access publishing, article downloads, and citations: Randomised controlled trial.
BMj 337, a568.
16
Evans, J. A. and J. Reimer (2009). Open access and global participation in science. Sci-
ence 323 (5917), 1025–1025.
Eysenbach, G. (2006). Citation advantage of open access articles. PLoS biology 4 (5), e157.
Furman, J. L. and S. Stern (2011). Climbing atop the shoulders of giants: The impact of
institutions on cumulative research. American Economic Review 101 (5), 1933–1963.
Gaule, P. and N. Maystre (2011). Getting cited: Does open access help? Research Pol-
icy 40 (10), 1332–1338.
Harnad, S. and T. Brody (2004). Comparing the impact of open access (OA) vs. non-OA
articles in the same journals. D-lib Magazine 10 (6).
Houghton, J., A. Swan, and S. Brown (2011). Access to research and technical information
in denmark.
Howard, J. (2011). The road from dissertation to book has a new pothole: The internet.
The Chronicle of Higher Education.
Imbens, G. W. and D. B. Rubin (2015). Causal inference in statistics, social, and biomedical
sciences. Cambridge University Press.
Lawrence, S. (2001). Free online availability substantially increases a paper’s impact. Na-
ture 411 (6837), 521–521.
McCabe, M. and C. M. Snyder (2014). Identifying the effect of open access on citations
using a panel of science journals. Economic Inquiry 52 (4), 1284–1300.
McMullan, E. (2008). Open access mandate threatens dissemination of scientific information.
Journal of Neuro-Ophthalmology 28 (1), 72–74.
Metcalfe, T. S. (2005). The rise and citation impact of astro-ph in major journals. Bulletin
of the American Astronomical Society 37, 555–557.
Metcalfe, T. S. (2006). The citation impact of digital preprint archives for solar physics
papers. Solar Physics 239 (1-2), 549–553.
Mokyr, J. (2002). The gifts of Athena: Historical origins of the knowledge economy. Prince-
ton University Press.
Murphy, K. M. and R. H. Topel (2003). The economic value of medical research. Measuring
the gains from medical research: An economic approach 15 (30), 125–146.
17
Murray, F., P. Aghion, M. Dewatripont, J. Kolev, and S. Stern (2009). Of mice and aca-
demics: Examining the effect of openness on innovation. Technical report, National Bureau
of Economic Research.
Packalen, M. and J. Bhattacharya (2015, January). Age and the trying out of new ideas.
Working Paper 20920, National Bureau of Economic Research.
Romer, P. M. (1990). Endogenous technological change. Journal of Political Economy 98 (5
pt 2).
Rosenbaum, P. R. and D. B. Rubin (1983). The central role of the propensity score in
observational studies for causal effects. Biometrika, 41–55.
Rosenbaum, P. R. and D. B. Rubin (1984). Reducing bias in observational studies using
subclassification on the propensity score. Journal of the American statistical Associa-
tion 79 (387), 516–524.
Sampat, B. and H. L. Williams (2015). How do patents affect follow-on innovation? evidence
from the human genome. Technical report, National Bureau of Economic Research.
Schwarz, G. J. and R. C. Kennicutt Jr (2004). Demographic and citation trends in astro-
physical journal papers and preprints. Bulletin of the American Astronomical Society 36,
1654–1663.
Scotchmer, S. (1991). Standing on the shoulders of giants: Cumulative research and the
patent law. The Journal of Economic Perspectives , 29–41.
Seamans, N. (2001). Electronic theses dissertations: 2001 survey of editors and publishers.
Staudt, J., H. Yu, R. P. Light, G. Marschke, K. Borner, and B. A. Weinberg (2017). High-
impact and transformative science (HITS) metrics: Definition, exemplification, and com-
parison. Working paper.
Stuart, E. A., H. A. Huskamp, K. Duckworth, J. Simmons, Z. Song, M. E. Chernew, and
C. L. Barry (2014). Using propensity scores in difference-in-differences models to estimate
the effects of a policy change. Health Services and Outcomes Research Methodology 14 (4),
166–182.
Suber, P. (2012). Open access. MIT Press.
18
Torvik, V. I. (2015). Mapaffil: A bibliographic tool for mapping author affiliation strings
to cities and their geocodes worldwide. In D-Lib magazine: the magazine of the Digital
Library Forum, Volume 21. NIH Public Access.
Van Noorden, R. (2014). Funders punish open-access dodgers. Nature.
Walker, T. (2004). Open access by the articles: An idea whose time has come? Nature Web
Focus .
Ware, M. and M. Monkman (2009). Publishers Research Consortium Report .
Williams, H. L. (2013). Intellectual property rights and innovation: Evidence from the
human genome. Journal of Political Economy 121 (1), 1–27.
19
Figure 1: Mean Trends of Outcome Variables Prior to the PMC Mandate.
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Notes–The MEDLINE sample contains all NIH and non-NIH articles published between 2003 and 2013 that are indexed in the
2016 MEDLINE baseline files. The journal sample contains non-NIH articles published in the same journal-year as at least
one NIH article, the full PRCA sample contains non-NIH articles harvested using the PubMed Related Citations Algorithm
(PRCA), and the 1-to-1 PRCA sample contains non-NIH articles most similar to each NIH article on the basis of the PRCA
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Figure 2: Estimated Impacts of the PMC Mandate on an NIH Article’s Probability of
Being Published in a Toll Access Journal.
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Notes–The MEDLINE sample contains all NIH and non-NIH articles published between 2003 and 2013 that are indexed in the
2016 MEDLINE baseline files. The journal sample contains non-NIH articles published in the same journal-year as at least
one NIH article, the full PRCA sample contains non-NIH articles harvested using the PubMed Related Citations Algorithm
(PRCA), and the 1-to-1 PRCA sample contains non-NIH articles most similar to each NIH article on the basis of the PRCA
similarity score. The 47 article-level covariates include backward citations, text-based metrics, MeSH term counts, author
counts, and sets of indicators for whether the author is a corporate entity, institution type, publication type, language, and
grant support. Also included are country and field fixed effects. Propensity scores are estimated, separately for each
comparison sample, using logistic regression on the 47 covariates. The trimmed samples eliminate articles with propensity
scores outside (0.1, 0.9). The stratified DID estimates are obtained by stratifying the samples on the propensity scores
(Appendix D.2), estimating DID models within each stratum, and then combining the within-stratum estimates into a final
composite estimate. The 95% confidence intervals are computed using standard errors clustered at the aggregated field level
(Appendix C).
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Figure 3: Dynamic Impacts of the PMC Mandate on an NIH Article’s Probability of Being
Published in a Toll Access Journal.
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Figure 4: Dynamic Impacts of the PMC Mandate on an NIH Article’s Probability of Being
Published in Science or Nature.
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Figure 5: Estimated Impacts of the PMC Mandate on an NIH Article’s Probability of
Being Published in Science or Nature.
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The journal sample contains non-NIH articles published in the same journal-year as at least one NIH article, the full PRCA
sample contains non-NIH articles harvested using the PubMed Related Citations Algorithm (PRCA), and the 1-to-1 PRCA
sample contains non-NIH articles most similar to each NIH article on the basis of the PRCA similarity score. The 47
article-level covariates include backward citations, text-based metrics, MeSH term counts, author counts, and sets of
indicators for whether the author is a corporate entity, institution type, publication type, language, and grant support. Also
included are country and field fixed effects. Propensity scores are estimated, separately for each comparison sample, using
logistic regression on the 47 covariates. The trimmed samples eliminate articles with propensity scores outside (0.1, 0.9). The
stratified DID estimates are obtained by stratifying the samples on the propensity scores (Appendix D.2), estimating DID
models within each stratum, and then combining the within-stratum estimates into a final composite estimate. The 95%
confidence intervals are computed using standard errors clustered at the aggregated field level (Appendix C).
24
Figure 6: Estimated Impacts of the PMC Mandate on the Count of 2-Year Forward
Citations.
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Notes–The MEDLINE sample contains all NIH and non-NIH articles published between 2003 and 2013 that are indexed in the
2016 MEDLINE baseline files. The journal sample contains non-NIH articles published in the same journal-year as at least
one NIH article, the full PRCA sample contains non-NIH articles harvested using the PubMed Related Citations Algorithm
(PRCA), and the 1-to-1 PRCA sample contains non-NIH articles most similar to each NIH article on the basis of the PRCA
similarity score. The 47 article-level covariates include backward citations, text-based metrics, MeSH term counts, author
counts, and sets of indicators for whether the author is a corporate entity, institution type, publication type, language, and
grant support. Also included are country, field, and journal fixed effects. Propensity scores are estimated, separately for each
comparison sample, using logistic regression on the 47 covariates. The trimmed samples eliminate articles with propensity
scores outside (0.1, 0.9). The stratified DID estimates are obtained by stratifying the samples on the propensity scores
(Appendix D.2), estimating DID models within each stratum, and then combining the within-stratum estimates into a final
composite estimate. The 95% confidence intervals are computed using standard errors clustered at the journal level.
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Figure 7: Dynamic Impacts of the PMC Mandate on the Number of 2-Year Forward
Citations an Article Receives.
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went into effect.
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Figure 8: Estimated Impacts of the PMC Mandate on the Count of 2-Year Forward
Citations from Authors Affiliated with Commercial Enterprises.
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Notes–The MEDLINE sample contains all NIH and non-NIH articles published between 2003 and 2013 that are indexed in the
2016 MEDLINE baseline files. The journal sample contains non-NIH articles published in the same journal-year as at least
one NIH article, the full PRCA sample contains non-NIH articles harvested using the PubMed Related Citations Algorithm
(PRCA), and the 1-to-1 PRCA sample contains non-NIH articles most similar to each NIH article on the basis of the PRCA
similarity score. The 47 article-level covariates include backward citations, text-based metrics, MeSH term counts, author
counts, and sets of indicators for whether the author is a corporate entity, institution type, publication type, language, and
grant support. Also included are country, field, and journal fixed effects. Propensity scores are estimated, separately for each
comparison sample, using logistic regression on the 47 covariates. The trimmed samples eliminate articles with propensity
scores outside (0.1, 0.9). The stratified DID estimates are obtained by stratifying the samples on the propensity scores
(Appendix D.2), estimating DID models within each stratum, and then combining the within-stratum estimates into a final
composite estimate. The 95% confidence intervals are computed using standard errors clustered at the journal level.
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Figure 9: Estimated Impacts of the PMC Mandate on the Count of 2-Year Forward
Citations from Authors Located in Poor/Developing Countries.
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Notes–The MEDLINE sample contains all NIH and non-NIH articles published between 2003 and 2013 that are indexed in the
2016 MEDLINE baseline files. The journal sample contains non-NIH articles published in the same journal-year as at least
one NIH article, the full PRCA sample contains non-NIH articles harvested using the PubMed Related Citations Algorithm
(PRCA), and the 1-to-1 PRCA sample contains non-NIH articles most similar to each NIH article on the basis of the PRCA
similarity score. The 47 article-level covariates include backward citations, text-based metrics, MeSH term counts, author
counts, and sets of indicators for whether the author is a corporate entity, institution type, publication type, language, and
grant support. Also included are country, field, and journal fixed effects. Propensity scores are estimated, separately for each
comparison sample, using logistic regression on the 47 covariates. The trimmed samples eliminate articles with propensity
scores outside (0.1, 0.9). The stratified DID estimates are obtained by stratifying the samples on the propensity scores
(Appendix D.2), estimating DID models within each stratum, and then combining the within-stratum estimates into a final
composite estimate. The 95% confidence intervals are computed using standard errors clustered at the journal level.
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Table 2: Magnitudes of Estimated Impact of the PMC Mandate on Publishing Patterns in Biomedicine.
2009 2010 2011 2012 2013 All
Total NIH Articles 92,646 99,968 104,136 104,176 107,549 508,475
NIH Articles in OA Journals 5,697 7,514 9,968 12,774 15,028 50,981
NIH Articles in TA Journals 86,949 92,454, 94,168 91,402 92,521 457,494
Proportion of NIH Articles in TA Journals 0.939 0.925 0.904 0.877 0.860 0.900
Effect Size: 0.01
Predicted Proportion 0.929 0.915 0.894 0.867 0.850
Predicted Count 86,023 91,454 93,127 90,360 91,446 452,410
Predicted Difference 926 1,000 1,041 1,042 1,076 5,076
Effect Size: 0.02
Predicted Proportion 0.919 0.905 0.884 0.857 0.840
Predicted Count 85,096 90,455 92,085 89,318 90,370 447,324
Predicted Difference 1,853 1,999 2,083 2,084 2,151 10,170
Effect Size: 0.03
Predicted Proportion 0.909 0.895 0.874 0.847 0.830
Predicted Count 84,170 89,455 91,044 88,277 89,295 442,241
Predicted Difference 2,779 2,999 3,124 3,125 3,226 15,253
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A Data Sources
I begin with six sources of raw data: 1) MEDLINE, 2) Web of Science, 3) the Directory
of Open Access Journals (DOAJ), 4) the MeSH vocabulary, 5) MapAffil, and 6) United
Nations National Accounts. From MEDLINE, I obtain a list of unique article IDs and
information about each article’s journal, grant support, publication date, publication type,
author count, MeSH terms, title, and abstract. The unique article IDs are called PubMed
identifiers (PMIDs), which are assigned to articles by the National Library of Medicine.
From Web of Science, I obtain a list of citing PMIDs. I also obtain, for each citing PMID,
a list of cited PMIDs (the citing PMID’s references). From the Directory of Open Access
Journals (DOAJ), I obtain a list of journals identified as being “open access”. From the
MeSH vocabulary data set, I obtain the tree structure of MeSH terms that the NLM uses
to classify articles in MEDLINE. From MapAffil, I obtain, for each PMID, information on
the affiliation of the first author, including country and type of affiliation (e.g., university,
hospital, etc.). From the United Nations National Accounts, I obtain data on per capita
GDP for a panel of countries. The following subsections will explain each data set in more
detail.
A.1 MEDLINE
MEDLINE is a bibliographic database created and maintained by the U.S. National Library
of Medicine (NLM). The database can be downloaded by anyone, free of charge.21 This
paper uses the 2016 baseline files.22 These are distributed by the NLM as 812 compressed
Extensible Markup Language (XML) files.23
I wrote a series of Perl scripts to extract data from the XML files and place them into
tab-delimited text files.24 The elements that I extract are:25
1. “Status” attribute
2. PMID (and the “Version” attribute)
3. NlmUniqueID
4. MeshHeadingList
5. GrantList
6. PublicationTypeList
21http://www.nlm.nih.gov/bsd/licensee/medpmmenu.html
22https://www.nlm.nih.gov/bsd/licensee/2016 stats/baseline med filecount.html
23XML is a markup language that organizes data into a format that is both human-readable and machine-
readable.
24These scripts (and the rest of the code used to produce the results in this paper) are freely-available in
the following GitHub respository: https://github.com/EconJoe/NIHMandate. The parsers rely heavily on
the XML::Simple module from the Comprehensive Perl Archive Network (CPAN).
25 See https://www.nlm.nih.gov/bsd/mms/medlineelements.html for a description of all elements in
MEDLINE.
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7. PubDate
8. MedlineDate
9. ArticleDate
10. ArticleTitle
11. Abstract and AbstractText
12. Language
The top-level element for each record (article) in the MEDLINE XML files is MedlineCita-
tion. This element has four attributes, but I am only interested in the “Status” attribute.
This attribute indicates how thoroughly the record’s information has been vetted. I only
use records with the status “MEDLINE” as these have undergone the most rigorous quality
review and are the only true MEDLINE records.
The PMID, or PubMed ID, is a unique identifier for every record in MEDLINE. The
PMID element also contains an attribute called “Version”. This attribute is included to deal
with the “versioning” publishing model, in which multiple versions of the same article are
published.26 The PMID element is crucial for linking the MEDLINE and Web of Science
data sets. There are 24,358,442 records in the 2016 baseline files. Because 317 PMIDs have
several “versions”, there are only 24,358,073 unique PMIDs.
The NLMUniqueID element is a seven, eight, or nine character identifier that uniquely
identifies the journal in which a record is published. It is crucial for linking jounal-level infor-
mation within MEDLINE and other NLM sources. There are 23,395 unique NLMUniqueID
in the 2016 baseline files. The mean NLMUniqueID contains 1,041 articles and the median
contains 89. 2,579 NLMUniqueID contain only a single article and The Journal of Biological
Chemistry contains 170,684 articles. In addition to using the NLMUniqueID as a linking
variable, I also use it to estimate journal fixed effects and to cluster the standard errors at
the journal level in some of the models in the paper.
Unfortunately, other sources of journal-level data, such as DOAJ, do not use the NL-
MUniqueID. Instead, they use the International Standard Serial Number (ISSN) to identify
journals. Thus, to link journal-level information in MEDLINE to these other data sources, I
need to use the ISSN. The ISSN is an eight-character value that uniquely identifies periodi-
cal publications, including journals. It is assigned by ISSN National Centers, not the NLM.
Thus, it is more universal and more useful than the NLMUniqueID for linking to non-NLM
sources. If a journal has both a print and electronic format, then each format will receive a
separate ISSN. Fortunately, MEDLINE typically include all formats, which allows me to link
data at the journal-level regardless of which ISSN format is used in non-NLM sources. The
ISSNLinking element is an ISSN that links all formats of the same journal. This element
also helps to uniquely identify journals with multiple ISSNs.
The MeshHeadingList element contains a list of all MeSH (Medical Subject Heading)
terms assigned to the record. MeSH terms are used to classify the content of each record
indexed in MEDLINE. NLM librarians read each article and determine which MeSH terms
26PLoS Contents is the only journal indexed in MEDLINE that uses the versioning model of publishing.
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apply to that article. Thus, they are librarian-supplied, not author-supplied. This eliminates
concerns about authors strategically choosing MeSH terms. The MeshHeadingList contains
the following elements: DescriptorName and QualifierName, each of which have the attribute
“MajorTopicYN”. As suggested by the names, DescriptorName describes the record content,
QualifierName qualifies the description, and “MajorTopicYN” indicates whether the MeSH
term is a major or minor topic of the article. For instance, “Fetal Growth Retardation”
might be a descriptor and “complications” might qualify the descriptor. The MeSH terms
are crucial for linking MEDLINE and the MeSH vocabulary. The article-level covariates
computed using the MeSH terms are: the 1) total number of descriptor terms and 2) total
number of qualifying terms that tag each article. I also use the MeSH terms to group articles
into fields and estimate field fixed effects – see Appendix C for the details.
The GrantList element contains a list of all grants that are acknowledged by a record. It
includes the grant number as well as the funding agency. I use the funding agency to identify
which are records are NIH-funded. The article-level covariates computed using the grant list
are: 1) an indicator for whether an article is NIH funded and 2) the count of non-NIH grants
that support an article.
The PublicationTypeList element contains a list of all publication types that characterize
an article. Like MeSH terms, these publication types are librarian-supplied. Examples of
publication types include “Journal Article”, “Review”, and “Retracted Publication”. There
are XX publication types27, and I combine them into 21 groups to include as article-level
covariates in models that I estimate. Two of the publication types are “Research Support,
N.I.H., Extramural” and “Research Support, N.I.H., Intramural”. I use this as an additional
source of information about which records are NIH funded.
MEDLINE has three date elements that I use to determine the publication date of each
record: PubDate, MedlineDate, and ArticleDate. PubDate follows a standard dating format,
making it very easy to identify the Year element. When dates do not follow this standard
format, they are found in the element MedlineDate. For these non-standard dates, I manually
code the year. In some cases, there is a year range instead of a single year. For these cases, I
take the first year in the range as the publication year. The element ArticleDate contains the
date that a publisher first publishes an electronic version of an article. ArticleDate always
follows a standard dating format, making it easy to identify the Year element. Often, the
date information in the PubDate or MedlineDate elements differs from the date information
in the ArticleDate element. This is because the electronic and print versions of articles
are often published on different dates. I take the minimum year as the relevant year of
publication. Typically, the PubDate and MedlineDate Year elements do not differ by more
than a year from ArticleDate Year element. I use the publication year to estimate a set of
year fixed effects in all models and also to define the pre and post PMC mandate periods
(before and after 2008).
The element ArticleTitle contains the complete English title for each record. If the article
is originally published in a different language, it is translated to English. The elements
Abstract and AbstractText contain the abstract for each record published in an English
language journal. Unlike titles, abstracts are not translated if they are originally published
in another language. The titles and the abstracts for each record are used to construct text
27See here for the full list: https://www.nlm.nih.gov/mesh/pubtypes.html
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metrics that are included as article-level covariates in estimated models. See Appendix B
for additional information on processing title and abstract text.
The element Language contains information on the language in which an article is pub-
lished. I create 10 indicator variables for 10 languages, which serve as article-level covariates
in models that I estimate. These languages are: English, German, French, Russian, Japanese,
Spanish, Italian, Chinese, and Other. I also include an additional indicator for articles whose
language is undetermined.
A.2 Web of Science
Clarivate Anlytics Web of Science (WOS) is a citation indexing database. Indeed, it is the
most widely used source of citation data.28 Unlike the rest of the data used in this paper,
the WOS data is not freely available. Instead, access to the data was negotiated in 20XX
and the data were delivered in December 2014. The data were delivered as 32 XML files
and include all articles published between 1950 and 2014 that are indexed in both WOS and
MEDLINE. There are 13,878,957 citing articles. The mean number of references is 22.76,
the median is 17, maximum of 6,310, and the standard deviation is 25.27. There are a total
of 14,328,197 cited articles. These receive an average of 22.04 citations, a median of 8, a
maximum of 251,686, and a standard deviation of 114.98.
WOS provides a wide variety of information about each article. However, for each article,
I only extract the PMID along with all of the PMIDs cited by the article (i.e, each PMID
and its references). The PMID allows me to link WOS records to MEDLINE records. The
references for each PMID allow me to construct various citation measures for each article and
author. Specifically, it allows me to construct the following outcome variables: total 2-year
forward citations, 2-year forward citations received by articles associated with a commercial
firm (see MapAffil data below), and 2-year forward citations received by articles associated
with poor/developing countries (see UN National Accounts data below). These data also
allow me to construct the following article-level covariates: count of backward citations and
count of backward citations to articles published in open access journals.
A.3 Directory of Open Access Journals (DOAJ)
The Directory of Open Access Journals (DOAJ) is an online directory that indexes peer-
reviewed open access journals. It began as a project at Lund University in 2002, but is now
an independent organization. The database can be downloaded by anyone, free of charge.29
The database is updated daily, and past versions are not readily available. I downloaded
the file on November 11, 2016, and will make it available upon request. The database is
distributed as a CSV (comma-separated) file. I use journals’ International Standard Serial
Number (ISSN) to match DOAJ data to the MEDLINE data.30
28Another common citation indexing database is Elsevier’s Scopus.
29Go to http://doaj.org/faqmetadata, and click ”Download the file to your computer”.
30See http://doaj.org/faqsearchresults for the fields contained in the DOAJ data file. This data allows
me to construct one of the main outcome variables of interest: an indicator variable for whether an article
is published in a toll access journal.
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A.4 MeSH Vocabulary
The MeSH vocabulary is a small set of XML files that contains all MeSH terms and infor-
mation about each term (e.g., the date it was introduced). These files are freely available
from the National Library of Medicine (NLM).31 I extract the following information for each
MeSH term: 1) the term itself, 2) a unique ID assigned to each MeSH term, and 3) the
branches of the MeSH tree on which the term is located. The MeSH terms can map to mul-
tiple branches on the MeSH tree. I use MeSH branches to characterize the field of articles,
which is described in Appendix C.
A.5 MapAffil
MapAffil (Torvik, 2015) is a data set containing information on the affiliation of MEDLINE
articles’ authors. The 2016 tranche of data consist of 37,412,190 PMID-authors. I extract
information on the country and type of institution that characterize each affiliation and use
the PMID to link this information to MEDLINE.
There are 929 countries in the MapAffil data. Country information is used to com-
pute author country fixed effects. Each affiliation is categorized into eight institution types:
commercial, educational, hospital, educational/hospital, government, military, other orga-
nization, or unknown. Institution type information is used to construct a set of indicator
variables characterizing the type of author affiliation for each article.
I also use the country and institution type information to construct citation measures that
only include citations from authors affiliated with particular countries or institution types.
In particular, I am able to identify citations that come from authors in poor/developing
countries and who are affiliated with commercial enterprises.
A.6 United Nations National Accounts
The UN National Accounts main aggregates are updated yearly by Economic Statistics
Branch of the UN Statistics Division. I use country aggregates on per capita GDP at current
prices (U.S. dollars).32 The data contain yearly GDP information on 220 countries between
1970 and 2015, though I only use data between 2003 and 2013. When data is missing for a
particular country-year, I linearly interpolate the value. For 2003-2013, the mean per capita
GDP is $14,681 (SD=$23,057) and the median is $4,809.
I use this data to classify each country into per capita GDP quintiles by year. I then link
this country-year level data to MapAfill, which enables me to link GDP quintile information
to each MEDLINE article. I use this information to identify citations that come from
authors in poor/developing countries. In this case, I define a country as poor/developing for
a particular year if it is in one of the bottom two quintiles of the per capita GDP distribution
in that year.
31http://www.nlm.nih.gov/mesh/filelist.html
32See: http://data.un.org/Data.aspx?q=GDP+per+capita&d=SNAAMA&f=grID%3a101%3bcurrID%3aUSD%3%3a1
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B Processing Title and Abstract Text
This section draws heavily on Staudt et al. (2017), which itself draws heavily on Packalen
and Bhattacharya (2015). As noted in Appendix A, I use a Perl script to extract the
ArticleTitle, Abstract, and AbstractText elements from each record (article) indexed in the
812 MEDLINE 2016 Baseline Files. After extraction, the script indexes all words, word pairs
and word triplets (1-, 2-, and 3-grams). It then processes each n-gram by performing the
following operations:
1. Convert all text to lower-case.
2. Eliminate 2- and 3-grams with words that cross the following characters: ,.?!;:)(}{][–.
3. Eliminate all remaining characters that are not alphanumeric.
4. Eliminate all n-grams that contain words appearing in the stopword list provided by the
NLM at this address: http://mbr.nlm.nih.gov/Download/2009/WordCounts/wrd stop
5. Eliminate all n-grams that contain the following character sequences: web, www, http,
pubmed, medline, clinicaltrialsgov.
6. Eliminate all n-grams that contain more than two adjacent numbers.
7. Eliminate all n-grams that have a length of less than three characters.
8. Keep all 1-grams with character length 3-29, 2-grams with character length 7-59, and
3-grams with character length 11-89.
9. Stem each word from each n-gram using the module Lingua::Stem from the Compre-
hensive Perl Archive Network (CPAN).
10. Index all the processed n-grams from each title and abstract into 812 tab-delimited
text files corresponding to the 812 MEDLINE XML files.
Once they are processed, I identify each n-gram’s “vintage” (“birth”) year – that is,
the year the n-gram first appears in the MEDLINE corpus. After an n-gram appears in the
MEDLINE corpus, I am able to identify all articles that use the n-gram in a title or abstract.
I use this information to identify, for every vintage, a set of “top” n-grams. An n-gram is
a top n-gram if it is in the top 0.01 percent of all n-grams in its vintage, in terms of the
total number articles that mention it after birth. Top n-grams are identified within vintage
because n-grams from earlier vintages will have more time to accumulate article mentions
than n-grams from later vintages. Thus, it does not make sense to compare n-grams that
have different vintages.
I use this information to construct three article-level covariates. First, I compute the
count of top n-grams that an article originates. An article originates a top n-gram if it uses
the top concept in its vintage year. If multiple articles use a top n-gram in its vintage year,
then that particular n-gram has multiple originators. Second, I compute the count of top
n-grams that an article adopts early – i.e. within 5 years of the n-gram’s vintage. Finally, I
compute the total number of n-grams, regardless of vintage or “top” status, that an article
uses in its title or abstract.
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C Aggregating MeSH Terms to Construct Fields
This section draws heavily on the Appendix of Staudt et al. (2017). They devise an algorithm
which uses the Medical Subject Headings (MeSH) that tag most articles in MEDLINE to
characterize the fields to which each article belongs. Note that Staudt et al. (2017) use the
2014 MEDLINE baseline files, but the current paper uses the 2016 MEDLINE baseline files.
There are 27,883 raw terms in the 2016 MeSH vocabulary and they vary widely in their
descriptive detail. For instance, some articles are tagged with general terms such as Body
Regions and some are tagged with more detailed terms such as Peritoneal Stomata. Thus,
in order to construct comparable fields, I aggregate all MeSH terms to a similar level of
descriptive detail.
To understand the aggregation method, it is important to first understand how MeSH
terms are organized. MeSH terms have a hierarchical structure. At the top of the hierarchy
(first-level terms) are 16 very general terms such as Anatomy, Organisms, and Diseases. Each
of these 16 first-level terms are identified by a unique capital letter. For instance, Anatomy
is identified by the letter A, Organisms is identified by B, and so on. Beneath each of these
first-level MeSH terms is a group of second-level MeSH terms. For instance, Body Regions
is a second-level MeSH term beneath the top-level term Anatomy. Each second-level MeSH
term is identified by the capital letter of the first-level MeSH term it is beneath and by
two numbers. For instance, Body Regions is identified by A01. Beneath each second-level
MeSH term is a group of third-level MeSH terms identified by the capital letter of the first-
level term it is beneath, the two numbers of the second-level term it is beneath, and three
subsequent numbers. For instance, Anatomic Landmarks is a third-level MeSH term under
Body Regions and is identified as A01.111. This structure continues to depths of up to 12
levels.
Aggregating MeSH terms (that is, classifying lower level MeSH terms as a part of higher
level MeSH terms) is complicated by the fact that most MeSH terms fall beneath multiple
higher level MeSH terms. Consider the MeSH term Asthma. This term has four separate
identifiers: C08.127.108, C08.381.495.108, C08.674.095, and C20.543.480.680.095. Thus,
Asthma falls under the first level MeSH term Diseases (identified by C). It also falls under
the second-level terms Respiratory Tract Diseases (C08) and Immune System Diseases (C20).
The problem arises because MEDLINE records only contain the MeSH terms themselves, not
their identifiers. For instance, if a MEDLINE record is tagged with the MeSH term Asthma,
it is not clear whether this is the Asthma that is beneath Respiratory Tract Diseases (C08)
or Immune System Diseases (C20).
Consider aggregating the raw MeSH term Asthma to the second-level – i.e., splitting it
between the second-level terms Respiratory Tract Diseases and Immune System Diseases. I
opt to simply assign half to each higher level term. Thus, an article originally tagged with
the raw term Asthma is now tagged with two second-level terms, each weighted by 1/2.
Now consider aggregating the raw MeSH term Asthma to the fourth-level. In this case,
Asthma must be split between the following fourth-level terms:
• Lung Diseases, Obstructive [C08.381.495] from C08.381.495.108
• Hypersensitivity, Immediate [C20.543.480] from C20.543.480.680.095
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• Asthma [C08.127.108] from C08.127.108
• Asthma [C08.674.095] from C08.381.495.108
In this case, a quarter of the raw term Asthma is assigned to each of these four fourth-level
terms. Thus, overall, 1/4 will be assigned to Lung Diseases, Obstructive, 1/4 to Hypersen-
sitivity, Immediate, and 1/4+1/4=1/2 to Asthma itself. Thus, an article originally tagged
with the raw term Asthma is now tagged with three fourth-level terms, two weighted by 1/4
and one weighted by 1/2.
A last complication is that most article are tagged by multiple raw MeSH terms. As an
example, suppose that, in addition to being tagged with Asthma, an article is also tagged with
the raw terms Neck (identified by A01.598) and Health Information Exchange (identified by
L01.700.253, L01.399.500.500, L01.313.500.500, and E05.318.308.940.968.625.500.500). By
the process discussed above, 1/4 of Health Information Exchange will be assigned to each of
the four fourth-level MeSH terms: Health Information Exchange itself (L01.700.253), Health
Information Management (L01.399.500), Medical Informatics (L01.313.500), and Data Col-
lection (E05.318.308). Since the lowest level of aggregation for Neck is the third-level, it
cannot be assigned to a fourth-level term. In this Neck is simply eliminated – it is too highly
aggregated.
Each of the original remaining MeSH terms, Asthma and Health Information Exchange,
are assumed to receive equal weight in characterizing the article. Under this assumption,
the article will be apportioned to each fourth level MeSH term as follows:
• 1/2*1/4=1/8 to Lung Diseases, Obstructive
• 1/2*1/4=1/8 to Hypersensitivity, Immediate
• 1/2*1/4=1/8 to Asthma
• 1/2*1/4=1/8 to Asthma
• 1/2*1/4=1/8 to Health Information Exchange
• 1/2*1/4=1/8 to Health Information Management
• 1/2*1/4=1/8 to Medical Informatics
• 1/2*1/4=1/8 to Data Collection
Obviously 1/8+1/8+1/8+1/8+1/8+1/8+1/8+1/8=1. Thus, an article that was origi-
nally tagged by the three raw MeSH terms Asthma, Neck and Health Information Exchange
is now apportioned between seven different fourth-level MeSH terms – Asthma receiving a
weight of 1/8+1/8 = 1/4 and the other six receiving a weight of 1/8 each.
In general, each MEDLINE article is apportioned across aggregated MeSH terms in
two stages. First, the original MeSH terms are equally apportioned across the higher-level
MeSH terms of which they are a part (e.g. apportion Asthma equally across Lung Diseases,
Obstructive, Hypersensitivity, Immediate, Asthma, and Asthma. Second, the higher-level
MeSH terms are weighted by the inverse of the number of original MeSH terms of the proper
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level that tag the article (e.g. the hypothetical article was tagged by three original MeSH
terms, but only two at the proper level of aggregation, and so each is weighted by 1/2).
Each article is assigned to the most highly weighted fourth-level MeSH term. In the
example above, the article would be assigned to Asthma, which received a weight of 1/4.
Ties are broken randomly. Thus, each article is assigned to a single aggregated “field”. These
fields are used to compute field fixed effects and cluster standard errors.
I also use raw MeSH terms to develop and alternative characterization of an article’s field.
In particular, I first identify the major Descriptor MeSH terms for each article. If there are
multiple major MeSH terms, I choose the first listed as the raw term to characterize the
field. This provides a less aggregated alternative way to compute field fixed effects.
D Propensity Score Estimation and Stratification
D.1 Estimating the Propensity Score
As is usual in the literature, I estimate propensity scores using logistic regression. This is done
separately for each of the four comparison samples – MEDLINE, Journal, Full PRCA, and
1-to-1 PRCA. In the base specification, I estimate the models allowing all 46 coviariates to
enter linearly. As a robustness check, I also estimate a model that includes, in addition to the
46 linear terms, 982 second order terms (i.e. all squared terms and pair-wise interactions).33
D.1.1 DID Setting
In the difference-in-differences (DID) setting, the treated group is the set of NIH-funded
articles that are published after the PMC mandate. Thus, I estimate eDID(x) = P (Wi =
1|Xi = x) = P (Ni = 1, Pi = 1|Xi = x). The DID estimates can be obtained for all
outcome variables. Recall that the toll access and Science/Nature indicators are analyzed
for the period 2003-2013, and the 2-year forward citation outcomes are analyzed for the
period 2003-2011. Thus, for each of the four comparison samples, I separately estimate the
propensity score for these two time periods. This results in a total of eight sets of estimated
propensity scores – two for each of the four comparison samples.
D.1.2 DDD Setting
In the triple differences (DDD) setting, the treated group is the set of NIH-funded articles,
published in toll access journals, after the PMC mandate. In this case, I estimate eDDD(x) =
P (Wi = 1|Xi = x) = P (Ni = 1, Pi = 1, Si = 1|Xi = x). Since there is no within-journal
variation in the toll access and Science/Nature indicators, the DDD estimates can only be
obtained for the 2-year forward citation variables. Thus, there is only a need to obtain
estimated propensity scores for the 2003-2011 period, which results in a total of four sets of
estimates – one for each of the four comparison samples.
33Since there are 46 covariates, there are 46 ∗ (46 + 1)/2 = 1, 081 second order terms. However, squared
indicator variables are redundant, and so are not included in the model, leaving 982 second order terms.
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D.2 Stratification on the Propensity Score
The idea of stratifying units by covariates goes back to Cochran (1968) and the idea of
stratifying on the propensity score dates to Rosenbaum and Rubin (1983, 1984). The basic
idea is that, by grouping observations with similar propensity scores into strata, a stratified
randomized experiment can be mimicked. That is, within strata, analyses can be performed
as if the treatment is randomly assigned. By stratifying on the propensity score instead of
the covariates, the dimensionality of the problem is reduced to manageable levels.34 As noted
by Imbens and Rubin (2015), stratification is less dependent on the correct specification of
the propensity score than is propensity score weighting. This is important because in the
present application, there is virtually no a priori information about the true propensity score.
Stratifying the sample on the propensity score requires two main decisions. First, the
number of strata must be chosen. Second, the cut points for each stratum must be chosen.
I automate these decisions by using an algorithm adapted from Imbens and Rubin (2015)
to the difference-in-differences (DID) and triple differences (DDD) settings. Specifically, let
Bij be a variable indicating whether article i is in stratum j = 1, ..., J . That is,
Bij =
{
1 if bj−1 ≤ eˆ(Xi) < bj
0 otherwise
BiJ =
{
1 if bJ−1 ≤ eˆ(Xi) ≤ bJ
0 otherwise
where bj−1 and bj are the upper and lower cut points for each stratum. The algorithm
chooses the number of strata J and the ranges for each strata (bj−1, bj]. It starts with a
single stratum J = 1. Within this stratum, the algorithm conducts a one-way ANOVA test
for the equality of the means of the log odds ratio for the four DID groups or the eight DDD
groups. This test yield an F-value. If this F-value is large, the propensity scores are quite
different, and the algorithm attempts to split this stratum into two strata that are more
similar. If the stratum is split, it will be split at the median value of the propensity score.
However, before splitting, the algorithm must ensure that the two new candidate strata each
have a sufficient number of observations to conduct analyses within these strata. That is,
before splitting, the algorithm checks whether the potential new strata have Ng > Nmin,g for
each DID group (g = 1, 2, 3, 4) or DDD group (g = 1, 2, 3, 4, 5, 6, 7, 8). It also checks whether
the total number of observations is sufficient N > Nmin. If the F-statistic is sufficiently small
and there are a sufficient number of observations within each of the new candidate strata,
then the single stratum is split in two. Otherwise, the stratum is not split. The algorithm
then repeats these steps within every new stratum created. The algorithm continues to split
strata until all F-statistics are sufficiently small or further splitting would result in strata
with too few observations to conduct the analysis.
The inputs for this algorithm are the threshold F-statistc for splitting a stratum, Fmax,
the minimum number of observations in each of the DID or DDD groups, Nmin,g, and the
34Given K dichotomous covariates, the number of strata is 2K , so the number of strata grows exponen-
tially. This means that some strata may have no observations, and others may have only treated or control
observations. Analysis cannot be carried out for such strata.
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minimum number of total observations within each stratum, Nmin. For the baseline analysis,
I choose Fmax = 2, Nmin,g = 100 for all g, and Nmin = 1000.
D.3 Obtaining Stratified DID/DDD Estimates
Once the articles in each sample are stratified, it is straight forward to estimate equations
(1) and (2) within each strata, and then combine these estimates into a single composite
estimate. Let δˆj be the estimate, within stratum j, of δ from equation (1) or (2). Let Nj
be the number of observations within stratum j. Then the ATT is δˆ =
∑J
1 (Nj/N)δˆj, where
J is the total number of strata and N is the total number of observations. Let Vˆj be the
estimated variance of the ATT estimator within stratum j. Then the variance of the ATT
estimator is given by Vˆ =
∑J
1 (Nj/N)
2Vˆj.
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Table A1.a: Summary Statistics for the MEDLINE Sample.
NIH Pre Comp. Pre NIH Post Comp. Post All
Mean SD Mean SD Mean SD Mean SD Mean SD
Outcome Variables
TA Journal 0.97 0.18 0.96 0.2 0.9 0.3 0.88 0.32 0.92 0.27
Science/Nature 0.01 0.08 0.01 0.08 0.01 0.09 0 0.07 0.01 0.08
2-Yr For. Cites (Total) 10.41 17.97 3.78 10.55 7.13 18.85 2.6 8.20 3.79 10.98
2-Yr Forward Cites (Com. Enterprise) 0.2 0.8 0.1 0.6 0.1 0.57 0.05 0.39 0.08 0.53
2-Yr Forward Cites (Dev. Country) 0.21 0.81 0.15 1.48 0.07 0.66 0.06 0.69 0.11 1.11
Covariates
Backward Cites 36.15 30.92 17.11 24.3 37.62 35.18 19.39 26.24 20.41 27.02
OA Backward Cites 0.52 1.41 0.25 0.98 1.34 2.7 0.67 1.83 0.52 1.6
Age 0 Top Concepts 0.02 0.2 0.01 0.16 0.03 0.22 0.02 0.19 0.02 0.18
Age ≤ 5 Top Concepts 0.33 0.94 0.19 0.72 0.27 0.84 0.17 0.67 0.2 0.72
Total Concepts 138.42 47.04 101.7 60.68 120.35 67.83 91.69 68.29 100.17 65.16
Total MeSH Descriptors 13.86 5.24 10.75 5.62 13.22 5.37 10.27 6.07 10.84 5.89
Total MeSH Qualifiers 9.01 5.8 6.44 5.06 8.68 5.93 6.26 5.35 6.63 5.35
Author Count 5.34 3.89 4.32 6.71 6.17 6.12 4.89 13.18 4.75 10.11
Corporate Author 0 0.01 0.01 0.11 0 0.01 0.01 0.09 0.01 0.1
Journal Article 0.99 0.12 0.91 0.29 0.98 0.15 0.91 0.28 0.92 0.27
Research Support, U.S. Gov’t, Non-P.H.S. 0.14 0.35 0.03 0.16 0.13 0.34 0.03 0.16 0.04 0.19
Research Support, U.S. Gov’t, P.H.S. 0.39 0.49 0.01 0.09 0.02 0.14 0 0.05 0.03 0.16
Research Support, ARRA 0 0 0 0 0 0.05 0 0.01 0 0.01
Research Support, Non-U.S. Gov’t 0.48 0.5 0.34 0.47 0.48 0.5 0.39 0.49 0.38 0.49
Review Article 0.11 0.32 0.12 0.33 0.12 0.32 0.1 0.3 0.11 0.31
English Abstract 0 0.02 0.07 0.26 0 0.02 0.06 0.23 0.06 0.23
Case Report 0.01 0.09 0.08 0.28 0.01 0.1 0.07 0.26 0.07 0.25
Comparative Study 0.12 0.32 0.09 0.29 0.06 0.24 0.06 0.23 0.08 0.26
Meta-Analysis 0 0.05 0 0.06 0.01 0.07 0.01 0.08 0 0.07
Evaluation Studies 0.02 0.14 0.02 0.15 0.01 0.11 0.02 0.13 0.02 0.14
Guideline 0 0.02 0 0.05 0 0.03 0 0.04 0 0.04
Multicenter Study 0.02 0.13 0.01 0.12 0.02 0.14 0.01 0.12 0.01 0.12
Observational Study 0 0 0 0 0 0.03 0 0.04 0 0.03
Randomized Controlled Trial 0.03 0.16 0.02 0.15 0.03 0.17 0.02 0.15 0.02 0.15
Technical Report 0 0.01 0 0.01 0 0.01 0 0.01 0 0.01
Twin Study 0 0.05 0 0.02 0 0.04 0 0.02 0 0.02
Validation Studies 0.01 0.1 0.01 0.09 0.01 0.08 0.01 0.08 0.01 0.09
Clinical Trial 0.03 0.16 0.03 0.16 0.02 0.13 0.01 0.12 0.02 0.14
Irregular Article 0.02 0.14 0.12 0.32 0.04 0.19 0.11 0.31 0.1 0.31
Other Language 0 0.01 0.02 0.14 0 0.01 0.01 0.12 0.02 0.12
English 1 0.02 0.89 0.31 1 0.02 0.92 0.26 0.92 0.27
German 0 0 0.01 0.11 0 0 0.01 0.1 0.01 0.1
French 0 0.01 0.02 0.12 0 0.01 0.01 0.1 0.01 0.11
Russian 0 0.01 0.01 0.1 0 0.01 0.01 0.09 0.01 0.09
Japanese 0 0 0.01 0.11 0 0 0.01 0.09 0.01 0.09
Spanish 0 0.01 0.01 0.11 0 0.01 0.01 0.1 0.01 0.1
Italian 0 0 0 0.06 0 0 0 0.04 0 0.05
Chinese 0 0.01 0.02 0.15 0 0.01 0.02 0.14 0.02 0.13
Other Grant Count 0.07 0.37 0.02 0.21 0.17 0.88 0.05 0.39 0.05 0.38
Commercial Affiliation 0.01 0.1 0.02 0.15 0.01 0.09 0.02 0.14 0.02 0.14
Educational Affiliation 0.65 0.48 0.45 0.5 0.65 0.48 0.49 0.5 0.49 0.5
Eductional/Hospital Affiliation 0.16 0.37 0.16 0.37 0.15 0.36 0.17 0.37 0.16 0.37
Government Affiliation 0 0.05 0.01 0.07 0 0.05 0.01 0.07 0 0.07
Hospital Affiliation 0.07 0.25 0.11 0.32 0.07 0.26 0.1 0.3 0.1 0.3
Military Affiliation 0 0.03 0 0.04 0 0.03 0 0.04 0 0.04
Organization Affiliation 0.09 0.29 0.1 0.3 0.1 0.29 0.09 0.29 0.1 0.29
Unkown Affiliation 0.02 0.13 0.15 0.35 0.02 0.15 0.12 0.33 0.12 0.33
Observations 448,326 3,605,437 508,475 3,877,126 8,439,364
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Table A1.b: Summary Statistics for the Journal Sample.
NIH Pre Comp. Pre NIH Post Comp. Post All
Mean SD Mean SD Mean SD Mean SD Mean SD
Outcome Variables
TA Journal 0.97 0.18 0.97 0.18 0.9 0.3 0.89 0.31 0.93 0.26
Science/Nature 0.01 0.08 0.01 0.1 0.01 0.09 0.01 0.08 0.01 0.09
2-Yr For. Cites (Total) 10.41 17.97 4.77 11.89 7.13 18.85 3.13 9.08 4.58 12.1
2-Yr Forward Cites (Com. Enterprise) 0.2 0.8 0.12 0.68 0.1 0.57 0.06 0.43 0.1 0.58
2-Yr Forward Cites (Dev. Country) 0.21 0.81 0.18 1.7 0.07 0.66 0.07 0.77 0.13 1.23
Covariates
Backward Cites 36.15 30.92 20.83 25.66 37.62 35.18 22.66 27.47 23.95 28.18
OA Backward Cites 0.52 1.41 0.31 1.09 1.34 2.7 0.78 1.97 0.62 1.74
Age 0 Top Concepts 0.02 0.2 0.02 0.17 0.03 0.22 0.02 0.2 0.02 0.19
Age ≤ 5 Top Concepts 0.33 0.94 0.23 0.77 0.27 0.84 0.19 0.71 0.22 0.76
Total Concepts 138.42 47.04 108.7 58.84 120.35 67.83 95.93 68.55 105.73 64.53
Total MeSH Descriptors 13.86 5.24 11.22 5.69 13.22 5.37 10.77 6.02 11.34 5.86
Total MeSH Qualifiers 9.01 5.8 6.84 5.21 8.68 5.93 6.64 5.42 7.03 5.45
Author Count 5.34 3.89 4.63 7.55 6.17 6.12 5.15 14.71 5.03 11.21
Corporate Author 0 0.01 0.01 0.08 0 0.01 0.01 0.07 0 0.07
Journal Article 0.99 0.12 0.91 0.29 0.98 0.15 0.91 0.28 0.92 0.27
Research Support, U.S. Gov’t, Non-P.H.S. 0.14 0.35 0.03 0.18 0.13 0.34 0.03 0.17 0.05 0.21
Research Support, U.S. Gov’t, P.H.S. 0.39 0.49 0.01 0.1 0.02 0.14 0 0.06 0.03 0.18
Research Support, ARRA 0 0 0 0 0 0.05 0 0.01 0 0.01
Research Support, Non-U.S. Gov’t 0.48 0.5 0.4 0.49 0.48 0.5 0.45 0.5 0.44 0.5
Review Article 0.11 0.32 0.11 0.32 0.12 0.32 0.1 0.3 0.11 0.31
English Abstract 0 0.02 0.01 0.11 0 0.02 0.01 0.09 0.01 0.09
Case Report 0.01 0.09 0.07 0.26 0.01 0.1 0.06 0.24 0.06 0.23
Comparative Study 0.12 0.32 0.1 0.3 0.06 0.24 0.06 0.23 0.08 0.27
Meta-Analysis 0 0.05 0 0.06 0.01 0.07 0.01 0.09 0.01 0.07
Evaluation Studies 0.02 0.14 0.03 0.16 0.01 0.11 0.02 0.14 0.02 0.15
Guideline 0 0.02 0 0.04 0 0.03 0 0.04 0 0.04
Multicenter Study 0.02 0.13 0.02 0.12 0.02 0.14 0.02 0.13 0.02 0.13
Observational Study 0 0 0 0 0 0.03 0 0.04 0 0.03
Randomized Controlled Trial 0.03 0.16 0.03 0.16 0.03 0.17 0.03 0.16 0.03 0.16
Technical Report 0 0.01 0 0.01 0 0.01 0 0.01 0 0.01
Twin Study 0 0.05 0 0.02 0 0.04 0 0.02 0 0.03
Validation Studies 0.01 0.1 0.01 0.09 0.01 0.08 0.01 0.09 0.01 0.09
Clinical Trial 0.03 0.16 0.03 0.17 0.02 0.13 0.01 0.12 0.02 0.15
Irregular Article 0.02 0.14 0.11 0.32 0.04 0.19 0.11 0.31 0.1 0.3
Other Language 0 0.01 0 0.06 0 0.01 0 0.05 0 0.05
English 1 0.02 0.98 0.12 1 0.02 0.99 0.11 0.99 0.11
German 0 0 0 0.03 0 0 0 0.03 0 0.03
French 0 0.01 0 0.05 0 0.01 0 0.05 0 0.05
Russian 0 0.01 0 0.04 0 0.01 0 0.03 0 0.03
Japanese 0 0 0 0.02 0 0 0 0.03 0 0.02
Spanish 0 0.01 0 0.05 0 0.01 0 0.06 0 0.05
Italian 0 0 0 0.02 0 0 0 0.01 0 0.02
Chinese 0 0.01 0 0.07 0 0.01 0 0.05 0 0.05
Other Grant Count 0.07 0.37 0.03 0.23 0.17 0.88 0.07 0.43 0.06 0.42
Commercial Affiliation 0.01 0.1 0.03 0.16 0.01 0.09 0.02 0.14 0.02 0.14
Educational Affiliation 0.65 0.48 0.5 0.5 0.65 0.48 0.52 0.5 0.53 0.5
Eductional/Hospital Affiliation 0.16 0.37 0.16 0.36 0.15 0.36 0.16 0.37 0.16 0.36
Government Affiliation 0 0.05 0.01 0.07 0 0.05 0.01 0.07 0.01 0.07
Hospital Affiliation 0.07 0.25 0.1 0.3 0.07 0.26 0.09 0.28 0.09 0.28
Military Affiliation 0 0.03 0 0.05 0 0.03 0 0.04 0 0.04
Organization Affiliation 0.09 0.29 0.11 0.31 0.1 0.29 0.1 0.3 0.1 0.3
Unkown Affiliation 0.02 0.13 0.11 0.31 0.02 0.15 0.1 0.3 0.09 0.29
Observations 448,326 2,714,446 508,475 3,078,109 6,749,356
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Table A1.c: Summary Statistics for the Full PRCA Sample.
NIH Pre Comp. Pre NIH Post Comp. Post All
Mean SD Mean SD Mean SD Mean SD Mean SD
Outcome Variables
TA Journal 0.97 0.18 0.96 0.19 0.9 0.3 0.88 0.32 0.93 0.26
Science/Nature 0.01 0.08 0.01 0.07 0.01 0.09 0 0.06 0.01 0.07
2-Yr For. Cites (Total) 10.45 18.05 5.33 12.06 7.17 19.03 3.89 11.17 5.59 13.69
2-Yr Forward Cites (Com. Enterprise) 0.21 0.8 0.14 0.73 0.11 0.58 0.07 0.5 0.12 0.65
2-Yr Forward Cites (Dev. Country) 0.21 0.81 0.18 0.76 0.07 0.67 0.08 1.03 0.14 0.87
Covariates
Backward Cites 36.09 30.95 23.64 27.76 37.54 35.17 26.83 30.64 27.78 30.54
OA Backward Cites 0.52 1.41 0.36 1.16 1.35 2.71 1.01 2.32 0.73 1.93
Age 0 Top Concepts 0.02 0.2 0.02 0.17 0.03 0.22 0.02 0.21 0.02 0.19
Age ≤ 5 Top Concepts 0.33 0.94 0.25 0.81 0.27 0.85 0.24 0.8 0.26 0.82
Total Concepts 138.39 47.1 117.79 56.95 120.12 68.02 105.82 70.59 116 63.37
Total MeSH Descriptors 13.87 5.26 12.32 5.54 13.25 5.38 12.46 5.8 12.65 5.61
Total MeSH Qualifiers 9.02 5.82 7.65 5.41 8.68 5.94 7.87 5.76 8 5.66
Author Count 5.34 3.9 4.72 3.25 6.19 6.16 5.4 3.83 5.21 4.01
Corporate Author 0 0.01 0.01 0.08 0 0.01 0 0.06 0 0.06
Journal Article 0.99 0.12 0.94 0.24 0.98 0.15 0.95 0.22 0.95 0.21
Research Support, U.S. Gov’t, Non-P.H.S. 0.14 0.35 0.03 0.18 0.13 0.34 0.03 0.18 0.06 0.23
Research Support, U.S. Gov’t, P.H.S. 0.39 0.49 0.01 0.11 0.02 0.14 0.01 0.07 0.05 0.22
Research Support, ARRA 0 0 0 0 0 0.05 0 0.01 0 0.02
Research Support, Non-U.S. Gov’t 0.48 0.5 0.46 0.5 0.49 0.5 0.53 0.5 0.49 0.5
Review Article 0.11 0.32 0.13 0.34 0.12 0.33 0.12 0.33 0.12 0.33
English Abstract 0 0.02 0.05 0.22 0 0.02 0.04 0.19 0.04 0.18
Case Report 0.01 0.1 0.04 0.19 0.01 0.1 0.03 0.17 0.03 0.17
Comparative Study 0.12 0.32 0.11 0.31 0.06 0.24 0.07 0.25 0.09 0.28
Meta-Analysis 0 0.05 0 0.06 0.01 0.07 0.01 0.09 0 0.07
Evaluation Studies 0.02 0.14 0.03 0.16 0.01 0.11 0.02 0.14 0.02 0.15
Guideline 0 0.02 0 0.04 0 0.03 0 0.04 0 0.03
Multicenter Study 0.02 0.13 0.02 0.12 0.02 0.14 0.02 0.14 0.02 0.13
Observational Study 0 0 0 0 0 0.03 0 0.04 0 0.03
Randomized Controlled Trial 0.03 0.16 0.02 0.15 0.03 0.17 0.03 0.17 0.03 0.16
Technical Report 0 0.01 0 0.01 0 0.01 0 0.01 0 0.01
Twin Study 0 0.05 0 0.02 0 0.04 0 0.03 0 0.03
Validation Studies 0.01 0.1 0.01 0.1 0.01 0.08 0.01 0.09 0.01 0.09
Clinical Trial 0.03 0.16 0.03 0.17 0.02 0.13 0.02 0.13 0.02 0.15
Irregular Article 0.02 0.14 0.07 0.26 0.04 0.19 0.07 0.25 0.06 0.24
Other Language 0 0.01 0.01 0.11 0 0.01 0.01 0.09 0.01 0.09
English 1 0.02 0.93 0.25 1 0.02 0.95 0.21 0.96 0.21
German 0 0.01 0.01 0.09 0 0 0.01 0.07 0.01 0.07
French 0 0.01 0.01 0.09 0 0.01 0.01 0.08 0.01 0.08
Russian 0 0.01 0.01 0.08 0 0.01 0 0.07 0 0.07
Japanese 0 0 0.01 0.08 0 0 0 0.07 0 0.07
Spanish 0 0.01 0.01 0.08 0 0.01 0.01 0.08 0 0.07
Italian 0 0 0 0.04 0 0 0 0.03 0 0.03
Chinese 0 0.01 0.02 0.12 0 0.01 0.01 0.11 0.01 0.1
Other Grant Count 0.07 0.37 0.03 0.26 0.17 0.89 0.11 0.55 0.08 0.5
Commercial Affiliation 0.01 0.1 0.03 0.16 0.01 0.09 0.02 0.14 0.02 0.14
Educational Affiliation 0.65 0.48 0.51 0.5 0.65 0.48 0.53 0.5 0.55 0.5
Eductional/Hospital Affiliation 0.16 0.37 0.16 0.37 0.15 0.36 0.17 0.38 0.16 0.37
Government Affiliation 0 0.05 0.01 0.07 0 0.05 0.01 0.07 0 0.07
Hospital Affiliation 0.07 0.25 0.09 0.29 0.07 0.26 0.08 0.28 0.08 0.28
Military Affiliation 0 0.03 0 0.04 0 0.03 0 0.04 0 0.04
Organization Affiliation 0.09 0.29 0.11 0.31 0.1 0.29 0.11 0.31 0.1 0.31
Unkown Affiliation 0.02 0.13 0.09 0.29 0.02 0.15 0.08 0.27 0.07 0.26
Observations 437,941 1,707,488 494,907 146,4350 4,104,686
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Table A1.d: Summary Statistics for the 1-to-1 PRCA Sample.
NIH Pre Comp. Pre NIH Post Comp. Post All
Mean SD Mean SD Mean SD Mean SD Mean SD
Outcome Variables
TA Journal 0.97 0.18 0.96 0.19 0.9 0.3 0.88 0.33 0.92 0.27
Science/Nature 0.01 0.08 0.01 0.08 0.01 0.09 0 0.06 0.01 0.08
2-Yr For. Cites (Total) 10.43 18.04 7.77 15.31 7.12 19.12 5.13 15.75 7.53 17.25
2-Yr Forward Cites (Com. Enterprise) 0.21 0.8 0.19 0.85 0.11 0.58 0.09 0.57 0.15 0.71
2-Yr Forward Cites (Dev. Country) 0.21 0.82 0.23 0.81 0.08 0.68 0.09 1.69 0.15 1.09
Covariates
Backward Cites 36.02 31 31.41 29.07 37.38 35.16 33.23 32.41 34.55 32.17
OA Backward Cites 0.52 1.41 0.48 1.36 1.35 2.73 1.27 2.53 0.93 2.17
Age 0 Top Concepts 0.02 0.2 0.02 0.19 0.03 0.22 0.03 0.23 0.03 0.21
Age ≤ 5 Top Concepts 0.34 0.94 0.35 0.97 0.27 0.85 0.3 0.9 0.31 0.92
Total Concepts 138.34 47.2 140.09 51.48 119.7 68.3 120.89 71.56 129.24 61.82
Total MeSH Descriptors 13.87 5.26 14.65 5.48 13.23 5.39 14.19 5.57 13.97 5.45
Total MeSH Qualifiers 9.01 5.82 9.78 6.07 8.65 5.94 9.58 6.26 9.25 6.05
Author Count 5.34 3.9 5.25 3.33 6.19 6.19 5.87 4 5.68 4.55
Corporate Author 0 0.01 0 0.04 0 0.01 0 0.04 0 0.03
Journal Article 0.99 0.12 0.98 0.14 0.98 0.15 0.97 0.16 0.98 0.14
Research Support, U.S. Gov’t, Non-P.H.S. 0.14 0.35 0.04 0.2 0.13 0.34 0.03 0.18 0.09 0.28
Research Support, U.S. Gov’t, P.H.S. 0.39 0.49 0.02 0.14 0.02 0.14 0.01 0.08 0.1 0.31
Research Support, ARRA 0 0 0 0 0 0.05 0 0.01 0 0.03
Research Support, Non-U.S. Gov’t 0.48 0.5 0.6 0.49 0.49 0.5 0.64 0.48 0.55 0.5
Review Article 0.11 0.32 0.12 0.32 0.12 0.33 0.12 0.32 0.12 0.32
English Abstract 0 0.02 0.03 0.18 0 0.02 0.02 0.16 0.01 0.12
Case Report 0.01 0.1 0.01 0.11 0.01 0.1 0.01 0.12 0.01 0.11
Comparative Study 0.12 0.32 0.13 0.33 0.06 0.24 0.07 0.25 0.09 0.29
Meta-Analysis 0 0.05 0 0.06 0.01 0.07 0.01 0.09 0 0.07
Evaluation Studies 0.02 0.14 0.03 0.16 0.01 0.12 0.02 0.13 0.02 0.14
Guideline 0 0.02 0 0.03 0 0.03 0 0.03 0 0.02
Multicenter Study 0.02 0.13 0.02 0.13 0.02 0.15 0.02 0.14 0.02 0.14
Observational Study 0 0 0 0 0 0.03 0 0.04 0 0.02
Randomized Controlled Trial 0.03 0.16 0.02 0.15 0.03 0.17 0.03 0.17 0.03 0.16
Technical Report 0 0.01 0 0.01 0 0.01 0 0.01 0 0.01
Twin Study 0 0.04 0 0.03 0 0.04 0 0.03 0 0.04
Validation Studies 0.01 0.1 0.01 0.1 0.01 0.09 0.01 0.08 0.01 0.09
Clinical Trial 0.03 0.16 0.03 0.17 0.02 0.13 0.02 0.13 0.02 0.15
Irregular Article 0.02 0.14 0.03 0.17 0.04 0.19 0.04 0.2 0.03 0.18
Other Language 0 0.01 0.01 0.08 0 0.01 0 0.07 0 0.05
English 1 0.02 0.97 0.18 1 0.02 0.97 0.16 0.98 0.12
German 0 0.01 0 0.06 0 0 0 0.05 0 0.04
French 0 0.01 0 0.06 0 0.01 0 0.06 0 0.04
Russian 0 0.01 0 0.05 0 0.01 0 0.05 0 0.04
Japanese 0 0 0 0.06 0 0 0 0.05 0 0.04
Spanish 0 0.01 0 0.05 0 0.01 0 0.05 0 0.04
Italian 0 0 0 0.03 0 0 0 0.02 0 0.02
Chinese 0 0.01 0.01 0.11 0 0.01 0.01 0.1 0.01 0.07
Other Grant Count 0.07 0.36 0.05 0.32 0.17 0.87 0.15 0.66 0.11 0.61
Commercial Affiliation 0.01 0.1 0.03 0.16 0.01 0.09 0.02 0.15 0.02 0.13
Educational Affiliation 0.65 0.48 0.57 0.49 0.64 0.48 0.57 0.5 0.61 0.49
Eductional/Hospital Affiliation 0.16 0.37 0.15 0.36 0.15 0.36 0.17 0.37 0.16 0.36
Government Affiliation 0 0.05 0 0.07 0 0.05 0.01 0.07 0 0.06
Hospital Affiliation 0.07 0.25 0.07 0.25 0.07 0.26 0.07 0.26 0.07 0.26
Military Affiliation 0 0.03 0 0.04 0 0.03 0 0.04 0 0.03
Organization Affiliation 0.09 0.29 0.13 0.34 0.09 0.29 0.12 0.32 0.11 0.31
Unkown Affiliation 0.02 0.13 0.04 0.2 0.02 0.15 0.05 0.22 0.03 0.18
Observations 431,647 431,647 481,002 481,002 1,825,298
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